On December 5th, The European Institute presented its Transatlantic Leadership Award to The Honorable Christine Lagarde, Managing Director of the International Monetary Fund and to The Honorable Elias Zerhouni, President of Global Research and Development at Sanofi and former Director of the U.S. National Institutes of Health, at the Annual Ambassadors’ Gala Dinner. Madame Lagarde was recognized for exercising uncommon leadership in seeking to resolve the European sovereign debt crisis and stem further contagion of the global economy. Dr. Zerhouni was honored for his pivotal role in furthering translational medical innovation to the benefit of global public health.
On October 4, 2011, The European Institute held a seminar in conjunction with the U.S. Department of Energy, European Commission and Japanese Ministry of Economy, Trade and Industry’s EU-Japan-U.S. Trilateral Critical Materials Initiative. The Honorable David Sandalow, U.S. Assistant Secretary of Energy for Policy and International Affairs, The Honorable Reinhard Bütikofer, Vice Chair of the European Parliament’s Group of the Greens/European Free Alliance and Member of the Committee on Industry, Research and Energy, European Parliament; and His Excellency Ichiro Fujisaki, Ambassador of Japan to the United States presented keynote remarks. Panelists included: Gwenole Cozigou, Director for chemicals, metals, mechanical, electrical, construction industries and raw materials, DG Enterprise and Industry at the European Commission; Herbert von Bose, Director for Industrial Technologies, DG Research and Innovation at the European Commission; Cyrus Wadia, Senior Policy Analyst, Environment and Energy Division at the U.S. Office of Science and Technology Policy; Charles Cogar, Legislative Director for U.S. Representative Mike Coffman; Komei Halada, Managing Director for the Center for Strategic Natural Resources at the Japanese National Institute for Materials Science; Keiichi Kawakami, Deputy Director General, Manufacturing Industries Bureau at the Japanese Ministry of Economy, Trade and Industry; Stephen Collocott, Group Leader, Novel Alloys, Magnetics and Drives at Australia’s Commonwealth Scientific and Industrial Research Organization; Anil Arora, Assistant Deputy Minister, Minerals and Metals Sector, Natural Resources Canada; Alain Rollat, Technology Development Manager for Rhodia Rare Earth Systems; Maurits Van Camp, Coach, Recycling and Extraction Technology Platform, Umicore; and Jim Sims, Vice President for Corporate Communications at Molycorp. The discussion was moderated by The Honorable Bart Gordon, Partner at K&L Gates LLP.
On September 21, 2011, The Honorable John Dalli, European Commissioner for Health and Consumer Policy offered his perspective on the parameters for responsible innovation and how the EU can best strike a balance between the pressing drive for new and innovative consumer products and consumer safety. He also the prospects and challenges for greater transatlantic cooperation on consumer safety policies and the shared imperative of insuring better public health policies for long term social and economic benefit.
At a special dinner event in Brussels on September 8, 2011, The Honorable Maroš Šefcovic, Vice President of the European Commission responsible for Inter-Institutional Relations and Administration, Ambassador Richard Boucher, Deputy Secretary-General of the Organization for Economic Cooperation and Development and Robert-Jan Smits, Director General of DG Research and Innovation at the European Commission addressed the vital need to continue investing in innovation during a time of economic crisis and budget constraints, as well as the ongoing institutional changes in Brussels and what they mean for doing business in Brussels.
On June 29, 2011, Stéphane Hogan, Head of Coordination Unit in Directorate Health of DG Research and Innovation and Giulia Del Brenna, Head of Unit for Food and Healthcare Industries, Biotechnology in DG Enterprise and Industry both of the European Commission, David Beier, Senior Vice President for Global Government and Corporate Affairs at Amgen, and Dr. Val Giddings, Senior Fellow at the Information Technology and Innovation Foundation addressed U.S. and EU approaches to spurring innovation in the biotechnology sector in a time of budgetary constraints and growing concerns over rising healthcare costs. The Honorable Bart Gordon, Partner at K&L Gates LLP and former Chairman of the U.S. House Committee on Science and Technology, moderated the discussion.
© COPYRIGHT THE EUROPEAN INSTITUTE 2009
You may share using our article tools. Please don't cut articles from our site and redistribute by email or post to the web.